Blog

Category

Dhaka Medical College Shares Results of Randomized Controlled Trial: Ivermectin & Doxycycline Benefits Patients with Mild to Moderate COVID-19

Dhaka Medical College and Hospital, a public medical college and hospital based in Dhaka, the capital of Bangladesh, houses one of the most prestigious medical schools and the country’s largest tertiary care hospital. Known as the most advanced of health institutions...

Real-World Evidence: The Case of Peru

Causality Between Ivermectin and COVID-19 Infection Fatality Rate Introduction Much has been said much about Peru and its use of Ivermectin as a treatment for the coronavirus. The South American country has been a point of reference regarding its use. The Peruvian...

Principal Investigators: Are Federal Grant Data Requirements Overly Onerous? Make Your Voice Heard & Participate in University of Arkansas Survey

The University of Arkansas is concerned about the proliferation of regulations governing research data. They suspect a growing number of principal investigators are as well and hence, they have created a research data management survey just for principal investigators...

“Operation Warp Speed” Moves to Warp 2: AstraZeneca Begins Phase 3, Experts Skeptical as Trump Administration Prepares for November 1 Vaccine Delivery, and Speed-Up May Involve an EUA

Monday, AstraZeneca said it has begun Phase 3 trials of AZD1222, its COVID-19 vaccine candidate. This makes them the third firm to be in Phase 3 for the virus. As chronicled by CNN August 31 and updated September 1, the vaccine is developed with Oxford University and...

Zagazig University Randomized Controlled Ivermectin Study Results Confirms PI Hypothesis: Drug Effective Against COVID-19

A principal investor from Zagazig University, Dr. Waheed Shouman, recently completed a randomized, open label, interventional trial titled “Use of Ivermectin as Prophylactic Option in Asymptomatic Family Close Contact for Patient with COVID-19.” Targeting 340...

The AstraZeneca Phase 3 COVID-19 Vaccine Study: Unprecedented Compression of Timeline of Est. Start Date to Est. Primary Completion Date

Is President Trump preparing to fast track the AstraZeneca COVID-19 vaccine known as AZD1222? According to a report in the Financial Times, this is exactly what is being contemplated as the administration would “bypass normal regulatory standards to fast-track”...